RecruitingNCT05169333
The Oxford Risk Factors And Non-Invasive Imaging Study
Sponsor
University of Oxford
Enrollment
250,000 participants
Start Date
Feb 23, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with cardiovascular diseases and cardiovascular risk factors. The study is currently recruiting participants at 37 locations. People eligible for this study include aged 18 Years to 99 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(45)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05169333
Related Trials
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
NCT076130991 location
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
NCT0424132814 locations
Longitudinal Validation of CIRC Technologies
NCT070817111 location
Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry
NCT0725624912 locations
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
NCT0761329458 locations